Seminário convidado
20 novembro 2018, 15:00 • Leonilde Morais Moreira
Editing of Mesenchymal Stem/Stromal cells (MSC) for safe anticancer therapies: genome engineering for the design of stable MSC expressing anticancer genes.
20 novembro 2018, 15:00 • Leonilde Morais Moreira
Editing of Mesenchymal Stem/Stromal cells (MSC) for safe anticancer therapies: genome engineering for the design of stable MSC expressing anticancer genes.